Results 161 to 170 of about 84,234 (301)
Bipolar Disorders, Volume 28, Issue 1, February 2026.ABSTRACT Background This was a 4‐year mirror‐image study of adult patients diagnosed with bipolar disorder (BD) assessing the effects on treatment continuation and hospitalisation between aripiprazole 1‐month (A1M), risperidone‐LAI (R‐LAI) and the monthly and 3‐monthly formulations of paliperidone palmitate (PP1M, PP3M).
Juan Antonio García‐Carmona +5 more
wiley +1 more source
Metabolic Syndrome Screening in Seriously Mentally Ill Patients: A Quality Improvement Project [PDF]
, 2016 A Project Submitted in Partial Fulfillment of the Requirements for the Degree of MASTER OF SCIENCE in Nursing ScienceSeriously mentally ill patients who are taking second-generation antipsychotics have a high risk of metabolic complications ...
Moreno, Annabel
core
Within‐drug benefit‐risk evaluation of olanzapine long‐acting injection at one and two years of treatment [PDF]
, 2014 Holland C. Detke +3 more
openalex +1 more source
Journal of Sleep Research, Volume 35, Issue 1, February 2026.ABSTRACT This study aimed to investigate the efficacy of a Danish adaption of a transdiagnostic sleep and circadian intervention, combining cognitive behavioural therapy for insomnia with chronotherapy. A randomised controlled trial enrolling 88 outpatients with depression, attention deficit disorder, or bipolar disorder suffering from insomnia or ...
Mette Kragh +5 more
wiley +1 more source
The FASEB Journal, Volume 40, Issue 1, 15 January 2026.Schematic diagram of the triggering mechanism of necroptosis after cerebral ischemia. First, CCL11 targetedly binds to CCR3 on the surface of astrocytes and upregulates the expression of CCR3. After CCR3 activation, it triggers the transcriptional activation of necroptosis.
Han Yin +10 more
wiley +1 more source
Future Journal of Pharmaceutical SciencesBackground Samidorphan is an opioid antagonist while Olanzapine is an effective medication for schizophrenia and bipolar disorder. A unique and accurate MS/HPLC approach due to simultaneous measurement of Olanzapine and Samidorphan is, therefore, more ...
Rambabu Kantipudi +1 more
doaj +1 more source
Frontiers in PharmacologyObjectivesOlanzapine is used for treating bipolar disorder (BPD); however, the optimal initial dosing regimen is unclear. The present study aimed to investigate the optimal olanzapine initial dosage in patients with BPD via model-informed precision ...
Xiao Chen +7 more
doaj +1 more source
Cost-Offsets of New Medications for Treatment of Schizophrenia [PDF]
Broad claims are frequently made that new medications will offset all or part of their costs by reducing other areas of Medicaid spending. In this paper we examine the net impact on spending for new drugs used to treat schizophrenia.
Richard G. Frank +2 more
core
Medicaid spending burden among beneficiaries with treatment-resistant depression. [PDF]
, 2019 AIM: To evaluate Medicaid spending and healthcare resource utilization (HRU) in treatment-resistant depression (TRD). MATERIALS & METHODS: TRD beneficiaries were identified from Medicaid claims databases (January 2010-March 2017) and matched 1:1 with ...
Greenberg, Paul E. +7 more
core +1 more source
Olanzapine: Preclinical and Clinical Profiles of a Novel Antipsychotic Agent [PDF]
, 2000 Gary D. Tollefson, Cindy C. Taylor
openalex +1 more source